Livewire Podcast

Patrick Poke at Livewire hosted us, and we talk Disney, our top picks in digital health, growth investing, and why we've been so optimistic.


I also recommend 'Billion Dollar Molecule', a mix of Barbarians at the Gate and Liar's Poker... but for pharmaceutical companies.


Available here.


From Livewire: Michael FrazisFounder and Portfolio Manager at Frazis Capital Partners, is positive about the outlook for equities. Despite the obvious challenges the world faces, a combination of monetary and fiscal stimulus, and economies that are beginning open back up, should present a perfect setup for growth equities. But that doesn’t mean investors can be blasé about what they buy. He warns that in some popular sectors, prices have gotten too high in some names.

“Even in the hottest parts of the market, where there’s companies trading on 25-35 times sales or more, there are companies trading on a tenth of that. I think it’s extraordinarily important now to dodge some of those companies.”

Timestamps

  • 2:57 - Michael's background and how it shaped his investing strategy

  • 5:05 - Why he's bullish and why rising interest rates are a risk

  • 8:53 - Will the bifurcation of growth and value stocks continue, or even accelerate?

  • 14:46 - Reconciling companies that consumers love but investors hate

  • 20:12 - Something 'strange' happened that caused Michael to buy Afterpay, why it's one of the most impressive businesses around, and what Tencent may be thinking of doing with it

  • 25:52 - What he sold, mistakes made and additions to the portfolio

  • 29:59 - Why the market is mispricing Disney (NYS:DIS)

  • 34:30 - Why Tesla (NAS:TSLA) reminds Michael of Apple (NAS:AAPL)

  • 37:25 - Michael responds to our three favourite questions

Books discussed:

Stocks discussed:

  • Afterpay

  • Alteryx

  • Progyny

  • Catasys

  • Livongo Health

  • Disney

  • Tesla

  • Apple

 

 Contact: michael@fraziscapitalpartners.com

The information in this website has been prepared and issued by Frazis Capital Partners Pty Ltd ABN 16 625
521 986 as a corporate authorised representative (CAR No. 1263393) of Frazis Capital Management Pty Ltd
ABN 91 638 965 910 AFSL 521445 (Frazis Capital or we or us). The information contained in this website is
for general information only and is not intended to provide you with financial advice or take into account
your objectives, financial situation or needs. You should consider, with your professional adviser, whether
the information is suitable for your circumstances.


Please note past investment performance is not a reliable indicator of future investment performance and
no guarantee of performance, the return of capital or a particular rate of return is provided. Whilst we
believe the material in this website is correct, no warranty of accuracy, reliability or completeness is given,
except for liability under statute which can’t be excluded.